Benoît J. Arsenault

15.8k total citations · 6 hit papers
170 papers, 8.6k citations indexed

About

Benoît J. Arsenault is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Benoît J. Arsenault has authored 170 papers receiving a total of 8.6k indexed citations (citations by other indexed papers that have themselves been cited), including 74 papers in Surgery, 73 papers in Cardiology and Cardiovascular Medicine and 48 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Benoît J. Arsenault's work include Lipoproteins and Cardiovascular Health (68 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (38 papers) and Cardiac Valve Diseases and Treatments (34 papers). Benoît J. Arsenault is often cited by papers focused on Lipoproteins and Cardiovascular Health (68 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (38 papers) and Cardiac Valve Diseases and Treatments (34 papers). Benoît J. Arsenault collaborates with scholars based in Canada, United States and Netherlands. Benoît J. Arsenault's co-authors include Jean‐Pierre Després, S. Matthijs Boekholdt, John J.P. Kastelein, Nicholas J. Wareham, Philip J. Barter, Kay‐Tee Khaw, Patrick Mathieu, Robert Ross, Ian J. Neeland and Frank B. Hu and has published in prestigious journals such as JAMA, Circulation and SHILAP Revista de lepidopterología.

In The Last Decade

Benoît J. Arsenault

160 papers receiving 8.4k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Waist circumference as a vital sign in clinical practice: a Consensus Statement from the IAS and ICCR Working Group on Visceral Obesity

2020 1.1k citations Robert Ross, Ian J. Neeland et al. Nature Reviews Endocrinology profile →
Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement

2019 917 citations Ian J. Neeland, Robert Ross et al. profile →
Association of LDL Cholesterol, Non–HDL Cholesterol, and Apolipoprotein B Levels With Risk of Cardiovascular Events Among Patients Treated With Statins

2012 577 citations S. Matthijs Boekholdt, Benoît J. Arsenault et al. profile →
Oxidized Phospholipids, Lipoprotein(a), and Progression of Calcific Aortic Valve Stenosis

2015 296 citations Romain Capoulade, Kwan L. Chan et al. profile →
Lipoprotein(a) and Oxidized Phospholipids Promote Valve Calcification in Patients With Aortic Stenosis

2019 208 citations Sotirios Tsimikas, Benoît J. Arsenault et al. profile →
Lifestyle and metabolic factors for nonalcoholic fatty liver disease: Mendelian randomization study

2022 117 citations Shuai Yuan, Benoît J. Arsenault et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Benoît J. Arsenault Canada	43	3.2k	3.2k	2.3k	1.9k	1.7k	170	8.6k
Ron C. Hoogeveen United States	54	4.2k 1.3×	3.1k 1.0×	2.7k 1.1×	2.6k 1.3×	1.7k 1.0×	252	11.5k
Kwang Kon Koh South Korea	48	3.4k 1.1×	2.4k 0.8×	3.3k 1.4×	2.4k 1.2×	1.9k 1.1×	173	9.6k
Aruna D. Pradhan United States	42	2.4k 0.8×	2.5k 0.8×	2.9k 1.3×	3.4k 1.8×	1.6k 0.9×	88	10.0k
Vasilios G. Athyros Greece	54	2.7k 0.8×	3.9k 1.2×	4.2k 1.8×	2.6k 1.4×	1.1k 0.7×	285	10.5k
Eric J.G. Sijbrands Netherlands	59	3.1k 1.0×	5.1k 1.6×	3.1k 1.3×	1.4k 0.7×	1.3k 0.8×	276	12.5k
Niki Katsiki Greece	48	1.6k 0.5×	2.0k 0.6×	2.6k 1.1×	1.9k 1.0×	1.5k 0.9×	299	8.6k
Marianne Benn Denmark	43	2.6k 0.8×	4.1k 1.3×	3.3k 1.4×	1.2k 0.6×	839 0.5×	121	8.6k
Ian J. Neeland United States	42	4.0k 1.3×	2.0k 0.6×	3.1k 1.3×	2.0k 1.0×	3.3k 1.9×	155	11.1k
Johan Ärnlöv Sweden	56	4.2k 1.3×	1.5k 0.5×	2.0k 0.9×	1.7k 0.9×	2.1k 1.2×	299	12.6k
Steven R. Jones United States	47	2.0k 0.6×	3.1k 1.0×	2.6k 1.1×	1.1k 0.6×	816 0.5×	183	7.5k

Countries citing papers authored by Benoît J. Arsenault

Since Specialization

Citations

This map shows the geographic impact of Benoît J. Arsenault's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benoît J. Arsenault with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benoît J. Arsenault more than expected).

Fields of papers citing papers by Benoît J. Arsenault

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benoît J. Arsenault. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benoît J. Arsenault. The network helps show where Benoît J. Arsenault may publish in the future.

Co-authorship network of co-authors of Benoît J. Arsenault

This figure shows the co-authorship network connecting the top 25 collaborators of Benoît J. Arsenault. A scholar is included among the top collaborators of Benoît J. Arsenault based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benoît J. Arsenault. Benoît J. Arsenault is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gagnon, Éloi, Dipender Gill, Jérôme Bourgault, et al.. (2025). RNA interference versus antibody-based PCSK9 inhibition for the prevention of cardiovascular disease: a drug-target Mendelian randomization study. Cardiovascular Research. 121(7). 1066–1075.

Manikpurage, Hasanga D., Marie‐Annick Clavel, Philippe Pîbarot, et al.. (2025). Impact of Lipoprotein(a) on Valvular and Cardiovascular Outcomes in Patients With Calcific Aortic Valve Stenosis. Journal of the American Heart Association. 14(6). e038955–e038955. 3 indexed citations

Gagnon, Éloi, Dipender Gill, Héléne T. Cronjé, et al.. (2025). Evaluating the Cardiometabolic Efficacy and Safety of Lipoprotein Lipase Pathway Targets in Combination With Approved Lipid-Lowering Targets: A Drug Target Mendelian Randomization Study. Circulation Genomic and Precision Medicine. 18(2). e004933–e004933. 1 indexed citations

Arsenault, Benoît J., André C. Carpentier, Paul Poirier, & Jean‐Pierre Després. (2024). Adiposity, type 2 diabetes and atherosclerotic cardiovascular disease risk: Use and abuse of the body mass index. Atherosclerosis. 394. 117546–117546. 12 indexed citations

Gobeil, Émilie, Jérôme Bourgault, Patricia L. Mitchell, et al.. (2024). Genetic inhibition of angiopoietin-like protein-3, lipids, and cardiometabolic risk. European Heart Journal. 45(9). 707–721. 17 indexed citations

Gagnon, Éloi, Jérôme Bourgault, Erik Abner, et al.. (2024). Genetic assessment of efficacy and safety profiles of coagulation cascade proteins identifies Factors II and XI as actionable anticoagulant targets. European Heart Journal Open. 4(3). oeae043–oeae043.

Gagnon, Éloi, Émilie Gobeil, Jérôme Bourgault, et al.. (2023). Genetic control of body weight by the human brain proteome. iScience. 26(4). 106376–106376. 1 indexed citations

Gagnon, Éloi, Patricia L. Mitchell, Hasanga D. Manikpurage, et al.. (2023). Impact of the gut microbiota and associated metabolites on cardiometabolic traits, chronic diseases and human longevity: a Mendelian randomization study. Journal of Translational Medicine. 21(1). 60–60. 48 indexed citations

Puri, Rishi, Romain Capoulade, Kwan L. Chan, et al.. (2023). Impact of C-reactive protein levels on lipoprotein(a)-associated aortic stenosis incidence and progression. European Heart Journal Open. 3(2). oead032–oead032. 7 indexed citations

10.

Manikpurage, Hasanga D., et al.. (2023). Sex‐Specific Impact of Body Weight on Atherosclerotic Cardiovascular Disease Incidence in Individuals With and Without Ideal Cardiovascular Health. Journal of the American Heart Association. 12(13). e028502–e028502. 2 indexed citations

11.

Gagnon, Éloi, Émilie Gobeil, Jérôme Bourgault, et al.. (2022). Mendelian randomization prioritizes abdominal adiposity as an independent causal factor for liver fat accumulation and cardiometabolic diseases. SHILAP Revista de lepidopterología. 2(1). 130–130. 14 indexed citations

12.

Arsenault, Benoît J.. (2022). From the garden to the clinic: how Mendelian randomization is shaping up atherosclerotic cardiovascular disease prevention strategies. European Heart Journal. 43(42). 4447–4449. 37 indexed citations

13.

Perrot, Nicolas, Jérôme Bourgault, Christian Couture, et al.. (2021). A trans‐omic Mendelian randomization study of parental lifespan uncovers novel aging biology and therapeutic candidates for chronic diseases. Aging Cell. 20(11). e13497–e13497. 10 indexed citations

14.

Kaiser, Yannick, Hasanga D. Manikpurage, Nicolas Perrot, et al.. (2021). Sex-Specific Associations of Genetically Predicted Circulating Lp(a) (Lipoprotein(a)) and Hepatic LPA Gene Expression Levels With Cardiovascular Outcomes: Mendelian Randomization and Observational Analyses. Circulation Genomic and Precision Medicine. 14(4). e003271–e003271. 16 indexed citations

15.

Desgagné, Véronique, Cécilia Légaré, Simon‐Pierre Guay, et al.. (2021). HDL-enriched miR-30a-5p is associated with HDL-cholesterol levels and glucose metabolism in healthy men and women. Epigenomics. 13(13). 985–994. 6 indexed citations

16.

Bourgault, Jérôme, Nicolas Perrot, Patricia L. Mitchell, et al.. (2021). Lipoprotein Proteomics and Aortic Valve Transcriptomics Identify Biological Pathways Linking Lipoprotein(a) Levels to Aortic Stenosis. Metabolites. 11(7). 459–459. 11 indexed citations

17.

Perrot, Nicolas, Sébastien Thériault, Sidwell Rigade, et al.. (2020). Lipoprotein-associated phospholipase A2 activity, genetics and calcific aortic valve stenosis in humans. Heart. 106(18). 1407–1412. 15 indexed citations

18.

Ross, Robert, Ian J. Neeland, Shizuya Yamashita, et al.. (2020). Waist circumference as a vital sign in clinical practice: a Consensus Statement from the IAS and ICCR Working Group on Visceral Obesity. Nature Reviews Endocrinology. 16(3). 177–189. 1094 indexed citations breakdown →

19.

Li, Zhonglin, Nathalie Gaudreault, Benoît J. Arsenault, et al.. (2020). Phenome-wide analyses establish a specific association between aortic valve PALMD expression and calcific aortic valve stenosis. Communications Biology. 3(1). 477–477. 12 indexed citations

20.

Capoulade, Romain, Kwan L. Chan, Patrick Mathieu, et al.. (2017). Autoantibodies and immune complexes to oxidation-specific epitopes and progression of aortic stenosis: Results from the ASTRONOMER trial. Atherosclerosis. 260. 1–7. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact